In this webinar, presenters discuss the data on COVID-19 vaccines in immunocompromised people, the role of additional doses of mRNA COVID-19 vaccines, patients who should be considered to receive these additional COVID-19 vaccine doses, results from the August 13, 2021, Advisory Committee on Immunization Practices (ACIP) meeting, and Centers for Disease Control and Prevention's (CDC) guidance on additional COVID-19 doses in immunocompromised people.
This webpage includes information and recommendations on PPE use in health care settings for COVID-19.
This short video teaches correct PPE use for healthcare personnel.
This website includes information for COVID-19 vaccination administration, storage and handing, reporting, and patient education for each specific vaccine.
The Centers for Disease Control and Prevention (CDC) provides answers to a variety of frequently asked questions related to COVID-19 vaccine booster shots.
The COVID-19 County Check Tool provides a snapshot of county levels of community transmission over the past 7 days. The tool also displays guidance on masking based on how the virus is spreading.
This toolkit contains ready-made materials you can use to inform your healthcare teams and other staff about the COVID-19 vaccine.
To help share clear consistent, and credible information about COVID-19 vaccines, nursing home leadership can use this toolkit for communicating with staff.
This webpage provides information on the vaccines that are approved and authorized in the United States to prevent COVID-19.
This webpage provides information on the safety and effectiveness of the COVID-19 vaccines.
This content offers detailed interim guidance for healthcare providers on evaluating and caring for patients with post-COVID conditions.
This webpage provides a situational update on the National Institute for Occupational Safety & Health's (NIOSH) recommendations regarding use of non-NIOSH approved respirators.
On this webpage, CDC provides Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States.
These interim considerations provide information on preparing for the initial assessment and management of anaphylaxis following COVID-19 vaccination.
This guidance for infection prevention and control for healthcare personnel during COVID-19 applies to all U.S. settings where healthcare is delivered, including home health. The Centers for Disease Control and Prevention (CDC) has updated select healthcare infection prevention and control (IPC) recommendations in response to COVID-19 vaccination, which are now summarized in this guidance.
This webpage provides information on on reporting options, data collection forms, form instructions, archived and upcoming trainings on the National Healthcare Safety Network (NHSN) Long-Term Care Facility (LTCF) COVID-19 Module.
This quick reference summarizes CDC’s strategies to optimize personal protective equipment (PPE) supplies in healthcare settings.
This webpage provides guidance on the different types of viral tests for SARS-CoV-2 available in the United States and their intended uses.
This webpage provides an overview of the causes and frequency of post-COVID conditions for healthcare providers.
This is a checklist of questions for potential COVID-19 vaccine recipients with guidance on how to proceed with administration of the COVID-19 vaccine.
This 30-minute course reviews best practices for effective COVID-19 vaccine administration and addresses recent COVID-19 recommendations presented by the Advisory Committee on Immunization Practices (ACIP) and the Centers for Disease Control and Prevention (CDC).
This webpage provides COVID-19 data for various populations and guidance on how to slow the spread.
The latest COVID-19 testing guidelines for nursing homes can be found on this webpage.
The certified equipment list is a tool to help respirator users, safety managers, industrial hygienists, and others to determine if the respirator they are currently using or considering using is NIOSH-certified and select the appropriate respirator to protect against the hazard(s) they are exposed to.
During this webinar, presenters discuss the Food and Drug Administration's (FDA) role in issuing Emergency Use Authorizations (EUAs) for certain monoclonal antibodies, options for compassionate use, the process for ordering and distributing monoclonal antibodies, and current data on using monoclonal antibodies for both non-hospitalized and immunocompromised patients. Presenters also cover preventing, diagnosing, and treating COVID-19 in immunocompromised patients, including the role of monoclonal antibodies, serologic testing, and potential third dose of COVID-19 vaccinations.